Thursday, January 22, 2009

Comparing Two Non- Pharmacological GERD (Gastroesophageal Reflux Disease) Treatments

Comparing Two Non- Pharmacological GERD (Gastroesophageal Reflux Disease) Treatments
According to an article published in Archives of Surgery, two non-pharmacological GERD (gastroesophageal reflux disease) treatments seem to be effective in lowering medication use and improving swallowing symptoms as well as the patient's voice. One of the assessed therapies appears to be effective in reducing heartburn and cough. The other one reduces regurgitation. Archives of Surgery is a JAMA/Archives journal.

Wednesday, January 21, 2009

Comparing Two Non- Pharmacological GERD (Gastroesophageal Reflux Disease) Treatments

According to an article published in Archives of Surgery, two non-pharmacological GERD (gastroesophageal reflux disease) treatments seem to be effective in lowering medication use and improving swallowing symptoms as well as the patient's voice. One of the assessed therapies appears to be effective in reducing heartburn and cough. The other one reduces regurgitation. Archives of Surgery is a JAMA/Archives journal. More at...

Commissioner Jerry Farrell, Jr. announced that genetic testing on the 5-lb unopened tub of King Nut peanut butter found by food inspectors last week at a West Haven distributor has produced the first independently confirmed genetic match for the salmonella strain responsible for the nationwide outbreak. This finding definitively links the peanut butter sample implicated in the recent outbreak back to the manufacturer, Peanut Corporation of America. More at...

Nationwide Medical/Surgical has recently announced they will carry the Flu Vaccine for the 2009-2010 flu season. They will carry flu vaccines made by several manufacturers in several different formats including 10-dose vials and pre-filled syringes. The 2007-2008 flu season was allegedly the worst year of the last four for adult deaths by flu and pneumonia. More at...

Clif Bar & Company announced a voluntary recall of CLIF® and LUNA® branded bars that contain peanut butter because the products have the potential to be contaminated with Salmonella. The recalled products contain peanut butter manufactured by Peanut Corporation of America (PCA). PCA is the focus of an investigation by the U.S. Food and Drug Administration (FDA) concerning a recent Salmonella outbreak thought to be caused by tainted peanut butter. More at...

In terms of diversity and sheer numbers, the microbes occupying the human gut easily dwarf the billions of people inhabiting the Earth. Numbering in the tens of trillions and representing many thousands of distinct genetic families, this microbiome, as it's called, helps the body perform a variety of regulatory and digestive functions, many still poorly understood. More at...

New research supports a modest beneficial effect of anakinra for rheumatoid arthritis patients, but warns against potential risks for serious infections and its use with other biologic medications. Rheumatoid arthritis is a chronic inflammatory disease affecting as many as one in 100 people worldwide. It affects the joints, making them stiff and painful. Anakinra is one of a new breed of arthritis drugs licensed in the past decade called 'biologics'. More at...

Arkansas has joined the growing list of states affected by an ongoing outbreak of Salmonella Typhimurium that began in early September. Four Arkansas residents have tested positive for the same Salmonella strain. The cases are spread across the state with no apparent connection that can be determined. More at...

Dr. Mark Horton, director of the California Department of Public Health (CDPH), today warned consumers not to handle or consume frozen Peanut Butter Cookie Dough distributed by Sweet Success Fundraising Inc, of Ontario, California because of potential contamination with Salmonella. The Department further recommends that any dough that has been thawed or baked should also be discarded. More at...

Tuesday, January 20, 2009

New Criteria For Measuring Tumour Size And Progression Will Help Ease Workloads In Clinical Trials

The first, formal revision of specific guidelines, known as RECIST, used by clinicians to measure tumour size and response to treatment, has been published today (Tuesday 20 January) in a special issue of the European Journal of Cancer (the official journal of ECCO - the European CanCer Organisation) [1]. Complete news at...

PREVIEW: Please join us for lunch and a preview on 27 January 2009, 1 - 2.30pm, Breast Cancer Haven, Effie Road, London, SW6 1TB Speakers: Caroline Hoffman, Clinical Director, Breast Cancer Haven. Dr Andrew Vallance-Owen, Bupa's Group Medical Director. Professor Dudley Sinnett, Consultant Breast Surgeon. Complete news at...

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a drug for treating stage IV malignant melanoma that can increase median overall survival when compared with standard of care dacarbazine (Bedford Laboratories' DTIC-Dome, generics) would earn a higher patient share in the U.S. (60 percent) than in Europe (40 percent), according to surveyed U.S. and European oncologists. Complete news at...

Dr Sarah Cant, Policy Manager at Breakthrough Breast Cancer, says: "This research, whilst interesting, is only relevant to a very small proportion of women - those with a strong family history but without a BRCA gene fault. The researchers suggest that these women could benefit from extra breast screening and taking tamoxifen to reduce their breast cancer risk. However, tamoxifen is not currently licensed for this use in the UK. Complete news at...

Researchers long ago established a link between inflammation, cancer and the compound nitric oxide, which may be produced when the immune system responds to bacterial infections, including those of the colon. However, the exact nature of the relationship was unknown - until now. Complete news at...

Researchers at Mayo Clinic have found that the experimental drug they are testing to treat a deadly form of thyroid cancer turns on a powerful tumor suppressor capable of halting cell growth. Few other cancer drugs have this property, they say. In the Feb. 15 issue of Cancer Research (available online Jan. 20), they report that RS5444, being tested in a Phase 1/2 clinical trial to treat anaplastic thyroid cancer, might be useful for treating other cancers. Complete news at...

A chemical commonly used in the manufacture of rubber products may cause cancer in workers regularly exposed to it, suggests research published ahead of print in Occupational and Environmental Medicine. The researchers base their findings on higher than expected rates of certain cancers, and deaths from the disease, among men working at a rubber chemicals plant in North Wales. Complete news at...